Gastric Cancer
Conditions
Interventions
Index test:Serum gastric function indicators (PG?, PG?, PGI/PGII ratio, G-17), conventional tumor markers (Hp antibody, CA72-4, CA19-9, CEA), combined with pathological diagnosis.
Sponsors
Nanfang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years, any gender; 2. Has undergone gastroscopy; 3. Able to understand and voluntarily sign the informed consent form; 4. No history of treatment for gastric cancer or precancerous lesions before enrollment; 5. Has not used any drugs in the past month that may affect gastric function or the results of serum/molecular marker tests (such as proton pump inhibitors, gastric mucosal protectants, etc.).
Exclusion criteria
Exclusion criteria: 1. Previous stomach surgery (such as partial gastrectomy, total gastrectomy, etc.); 2. Presence of severe underlying diseases (such as severe heart failure, liver and kidney dysfunction, mental disorders); 3. Pregnancy or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensitivity;area under the curve;specificity; | — |
Countries
China
Contacts
Public ContactXiong Yufeng
Nanfang Hospital of Southern Medical University
Outcome results
None listed